Risk factors for asymptomatic atrial fibrillation in patients with COPD

E. Samorukova (Moscow, Russian Federation), E. Leonova (Moscow, Russian Federation), T. Adasheva (Moscow, Russian Federation), V. Zadionchenko (Moscow, Russian Federation), A. Malyavin (Moscow, Russian Federation), S. Pavlov (Moscow, Russian Federation)

Source: International Congress 2018 – Cardiovascular morbidities in COPD
Session: Cardiovascular morbidities in COPD
Session type: Thematic Poster
Number: 744
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Samorukova (Moscow, Russian Federation), E. Leonova (Moscow, Russian Federation), T. Adasheva (Moscow, Russian Federation), V. Zadionchenko (Moscow, Russian Federation), A. Malyavin (Moscow, Russian Federation), S. Pavlov (Moscow, Russian Federation). Risk factors for asymptomatic atrial fibrillation in patients with COPD. 744

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for new-onset atrial fibrillation in patients with asthma-COPD overlap syndrome (ACOS)
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


OSA and atrial fibrillation
Source: Sleep and Breathing Conference 2021
Year: 2021


Prevalence and clinical predictors of sleep apnea in patients with paroxysmal atrial fibrillation
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019


Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
Source: Eur Respir J 2007; 30: Suppl. 51, 707s
Year: 2007

Atrial fibrillation and stroke risk in relation to COPD and chronic productive cough
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013

Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006

Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

The role of interleukin 6 on incident atrial fibrillation in COPD patients
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Atrial fibrillation in critical care patients with respiratory failure: Incidence and clinical effects
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012

Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Evaluation of a new cardiac arrhythmias predictor in patients with COPD
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018


Is COPD a risk factor for electrocardiographic abnormalities and cardiac arrhythmias?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016

Unexpected high prevalence of left ventricular cardiopathy in patients with COPD
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005

Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018


Atrial fibrillation is not a predictor of in-hospital mortality in pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 80s
Year: 2007